申请人:Conforma Therapeutics Corporation
公开号:EP2145888A1
公开(公告)日:2010-01-20
Heterobicyclic compounds of formula I are described and demonstrated to have utility as Heat Shock Protein 90 (HSP90) inhibiting agent. Method of synthesis and use of such compounds are also described.
描述并证明了式 I 的杂
双环化合物作为热休克蛋白 90(HSP90)
抑制剂的实用性。还描述了合成和使用此类化合物的方法。